Skip to content
AwardedCzechiaGoodsCZK 647,318,515

Dodávky léků – Léčivá látka pembrolizumab – ATC L01FF02 – opakovaná VZ

Published
Published 20 March 2025
Deadline
Closed 23 April 2025

Overview

Předmětem plnění Veřejné zakázky jsou průběžné dodávky léčivého přípravku s obsahem léčivé látky pembrolizumab – ATC L01FF02. LL – pembrolizumab, léková forma 25MG/ML INF CNC SOL 1X4ML, měrná jednotka 1X4ML/100MG, množství 18 500

Key details

Country
Czechia
Status
Awarded
Category
Goods
Estimated value
CZK 647,318,515
Procedure
Open
Published
20 March 2025
Deadline
Closed
Classification (CPV)
Antineoplastic agents

Award outcome

Awarded value
CZK 647,318,515
Award date
28 April 2025
Contract period
16 May 2025 → 25 April 2029
Winner
  • Merck Sharp & Dohme s.r.o.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    20 May 2025

  2. Contract Notice

    20 March 2025

Contracting authority

  • Fakultní Thomayerova nemocnice

    Procuring entity

    Praha, Czechia

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Dodávky léků – Léčivá látka pembrolizumab – ATC L01FF02 – opakovaná VZ — won by Merck Sharp & Dohme s.r.o. — Skim